Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01833 is a long intergenic non-coding RNA (lncRNA) gene identified by the Ensembl gene ID ENSG00000276229. It does not code for a protein and its functional characterization remains limited. Some studies associate alterations in its expression with glioblastoma and lung adenocarcinoma, but no evidence supports its role as a direct therapeutic target. LINC01833 may be involved in the regulation of gene expression, typical of lncRNAs, but the mechanistic and biological implications are not yet clear.
No mechanisms of action for drugs targeting LINC01833 are reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LINC01833.